Centre for Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK.
Gut. 2013 May;62(5):695-707. doi: 10.1136/gutjnl-2011-301775. Epub 2012 Jun 8.
Mutations in the nucleotide-binding oligomerisation domain-containing protein 2 (NOD2) gene remain the strongest genetic determinants for Crohn's disease (CD). Having previously identified vimentin as a novel NOD2-interacting protein, the authors aimed to investigate the regulatory effects of vimentin on NOD2 function and the association of variants in Vim with CD susceptibility.
Coimmunoprecipitation, fluorescent microscopy and fractionation were used to confirm the interaction between NOD2 and vimentin. HEK293 cells stably expressing wild-type NOD2 or a NOD2 frameshift variant (L1007fs) and SW480 colonic epithelial cells were used alongside the vimentin inhibitor, withaferin A (WFA), to assess effects on NOD2 function using the nuclear factor-kappaB (NF-κB) reporter gene, green fluorescent protein-LC3-based autophagy, and bacterial gentamicin protection assays. International genome-wide association meta-analysis data were used to test for associations of single-nucleotide polymorphisms in Vim with CD susceptibility.
The leucine-rich repeat domain of NOD2 contained the elements required for vimentin binding; CD-associated polymorphisms disrupted this interaction. NOD2 and vimentin colocalised at the cell plasma membrane, and cytosolic mislocalisation of the L1007fs and R702W variants correlated with an inability to interact with vimentin. Use of WFA demonstrated that vimentin was required for NOD2-dependent NF-κB activation and muramyl dipeptide-induced autophagy induction, and that NOD2 and vimentin regulated the invasion and survival properties of a CD-associated adherent-invasive Escherichia coli strain. Genetic analysis revealed an association signal across the haplotype block containing Vim.
Vimentin is an important regulator of NOD2 function and a potential novel therapeutic target in the treatment of CD. In addition, Vim is a candidate susceptibility gene for CD, supporting the functional data.
核苷酸结合寡聚化结构域蛋白 2(NOD2)基因中的突变仍然是克罗恩病(CD)最强的遗传决定因素。作者先前发现波形蛋白是 NOD2 的一种新的相互作用蛋白,旨在研究波形蛋白对 NOD2 功能的调节作用以及 Vim 变异与 CD 易感性的关联。
使用免疫共沉淀、荧光显微镜和分馏来确认 NOD2 和波形蛋白之间的相互作用。使用稳定表达野生型 NOD2 或 NOD2 移码变异体(L1007fs)的 HEK293 细胞和 SW480 结肠上皮细胞,以及波形蛋白抑制剂 withaferin A(WFA),使用核因子-κB(NF-κB)报告基因、绿色荧光蛋白-LC3 基于自噬和细菌庆大霉素保护测定来评估对 NOD2 功能的影响。使用国际全基因组关联荟萃分析数据来测试 Vim 中的单核苷酸多态性与 CD 易感性的关联。
NOD2 的亮氨酸丰富重复结构域包含与波形蛋白结合所需的元素;与 CD 相关的多态性破坏了这种相互作用。NOD2 和波形蛋白在细胞膜上共定位,并且 L1007fs 和 R702W 变体的细胞质定位错误与无法与波形蛋白相互作用相关。使用 WFA 表明,波形蛋白是 NOD2 依赖性 NF-κB 激活和 muramyl dipeptide 诱导的自噬诱导所必需的,并且 NOD2 和波形蛋白调节与 CD 相关的粘附侵袭性大肠杆菌菌株的侵袭和存活特性。遗传分析显示在包含 Vim 的单倍型块上存在关联信号。
波形蛋白是 NOD2 功能的重要调节剂,也是治疗 CD 的潜在新治疗靶点。此外,Vim 是 CD 的候选易感基因,支持功能数据。